Locally-Advanced HCC:

Slides:



Advertisements
Similar presentations
Disclosures Participated in the following Advisory Boards: Gilead
Advertisements

Intermediate stage HCC management
Staging Strategy and Treatment for Patients With HCC
DEBATE: What is the Optimal Sequence of Therapies for Stage II-III Adenocarcinoma of the Proximal Stomach? Michael A. Choti, MD Department of Surgery UT.
Great Debates & Updates in GI Malignancies
Radiotherapeutic Option in Management of Hepatocellular Carcinoma
High Intensity Focused Ultrasound (HIFU) for Liver Tumour Dr Dai Wing Chiu Queen Mary Hospital.
High-Intensity Focused Ultrasound for Hepatocellular Carcinoma Joint Hospital Surgical Grand Round Queen Mary Hospital 19/10/2013.
Current Evidence in Ablative Therapy for Hepatocellular Carcinoma Joint Hospital Surgical Grand Round Dr Chu Ka Wan Queen Mary Hospital.
Management of colorectal cancer with liver metastasis Dr. Vivian Lee Department of Surgery, UCH.
Interventional Oncology Michael Kotton MD October 27, 2012.
Long-Term Survival Following Hepatectomy for Hepatocellular Carcinoma Sheung Tat FAN Department of Surgery, The University of HongKong Chair Professor.
DEBATE: What is the Optimal Strategy for Liver Only Metastatic Colon Cancer? Michael A. Choti, MD Department of Surgery UT Southwestern Medical Center.
Joint Hospital Surgical Grand Round 16th Jan 2010 Dr James Fung Department of Surgery United Christian Hospital.
62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.
Journal Meeting 時間 : AM 07:30 日期 : 06/29/2007 地點 : 胸腔外科辦公室 報告人 : R2 許博順.
Hepatocellular Carcinoma
Radiofrequency Ablation of Lung Cancer
Ayman Abdo MD, AmBIM, FRCPC
Management of Colorectal Liver Metastasis
Hepatocellular Carcinoma Aaron Wagner MS IV November 12, 2008.
Hepatocellular Carcinoma Detection and Treatment
Liver Cancer Management with Y90 Glass Microspheres – TheraSphere Experience and Challenges in HCC Thomas Lauenstein, MD Department of Diagnostic and.
Liver surgery AnatomyHepatectomy Liver tumors BenignMalignant.
Dr SH Chok Department of Surgery Ruttonjee & Tang Shiu Kin Hospitals
Biliary Tumors Cholangiocarcinoma and Cancer of the Gall Bladder
HCC Guidelines and recommendation Typical feature (wash in/wash out) New mass/nodule NoYes Alternative imaging technique Atypical featureTypical.
Hepatocellular Carcinoma Diagnostic and Therapeutic Strategies
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Colorectal Cancer Early detection of disease Precise Staging.
HEPATOCELLULAR CARCINOMA Monton. HCC in Thailand Most common cancer in Thai male Incidence 5 x 100,000 / year Male : female = 3-8:1 Age > 40 yr.
Hepatocellular Carcinoma and Liver Transplantation TTS Key Opinion Leaders Meeting Montreal, April 2007 Mazen Hassanain MBBS, FRCS(C) Assistant Professor.
4 YEARS SURVIVAL OF 100 HCC PATIENTS TREATED WITH DC BEAD: A RETROSPECTIVE ANALYSIS Marta Burrel Vascular Interventional Unit Barcelona Clinic Liver Cancer.
ACRIN 6673 Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma in Cirrhotic Patients: A Multi-Center Study.
Hamid Tavakkoli, MD Associate Prof. of Gastroenterology.
SYNCHRONOUS COLORECTAL AND LIVER RESECTION J Peter A Lodge MD FRCS HPB and Transplant Unit St James’s University Hospital Leeds LS9 7TF 2006 Association.
Multicenter Study of Down-staging of Hepatocellular Carcinoma (HCC) to within Milan Criteria before Liver Transplantation Neil Mehta, MD; Jennifer Guy,
Transileocolic portal vein embolisation
HCC Guidelines
L IVER TRANSPLANT IN HEPATOCELLULAR CARCINOMA. O UTLINE Indications Milan Criteria Expanded Milan Criteria (UCSF) Upto 7 Criteria MELD Scoring and T staging.
HCC Guidelines and recommendation Diagnostic algorithm and recall policy.*One imaging technique only recommended in centers of excellence with high-end.
Hamid Tavakkoli, MD Associate Prof. of Gastroenterology.
CLINICAL OUTCOME OF 251 PATIENTS WITH EXTRAHEPATIC METASTASIS AT INITIAL DIAGNOSIS OF HEPATOCELLULAR CARCINOMA: DOES TRANSARTERIAL CHEMOEMBOLIZATION IMPROVE.
Treatment Strategy for Recurrent Hepatocellular Carcinoma: Salvage Transplantation, Repeated Resection, or Radiofrequency Ablation? Albert C. Y. Chan,
Management of Hepatocellular carcinoma
Gallbladder Cancer Surgical Management
K Nouso, K Miyahara, D Uchida, K Kuwaki, N Izumi, M Omata, T Ichida, M Kudo, Y Ku, N Kokudo, M Sakamoto, O Nakashima, T Takayama, O Matsui, Y Matsuyama,
HCC with bile duct tumor thrombi (HCC c BDTT) disease review 1.
Liver mass Mazen Hassanain. Radiology Arterial enhancement: adenoma, FNH, hemangioma, HCC, NET mets Portal enhancement: CRC liver mets.
Two-Stage Hepatectomy for Unresectable Metastases :
Dustin Thompson, MD Associate Staff  |  Interventional Radiology
PANCREATODUODENECTOMY + MULTIVISCERAL RESECTION YES/NO
Hepatocellular Carcinoma: Diagnosis and Management
TACE of Metastatic HCC to the Pleura
Cancer Hospital & Institute, Chinese Academy of Medical Sciences
NESIR Case Presentation 5/8/17
Barcelona Clinic Liver Cancer (BCLC) staging classification and treatment schedule. Patients with very early hepatocellular carcinoma (HCC) (stage 0) are.
Liver Transplantation: 50 years
Proposal of a simplified treatment algorithm in patients with cancer and liver cirrhosis. 1 Both tumour- and liver-related prognosis should be taken into.
The 44th Congress of the Korean Association of HBP Surgery
Improved survival outcomes after resection of ductal adenocarcinoma in the body and tail of the pancreas: A single center 10 years’ experience Seong.
Alice C. Wei, MDCM, MSc, FRCSC, FACS
HEPATOCELLULAR CARCINOMA (HCC) at
高雄長庚 大腸直腸外科 吳昆霖 盧建璋, 陳鴻華, 李克釗, 胡萬祥, 張家駱, 蔡鎧隆, 林岳民, 鄭功全
Epidemiology & First option of treatment
KAHBPS , Gyeongju, Korea Long-term outcome after resection of huge hepatocellular carcinoma ≥10 cm: Single-institution experience with 471 patients:
Professor of Internal Medicine, HBP unit
Bile duct invasion itself can be the prognosis factor in early HCC
Prognosis of angiosarcoma at different anatomic sites
Prognostic effect of complete pathologic response following TACE on HCC patients undergoing liver resection or transplantation Prognostic effect of complete.
Multidisciplinary team approach to hepatocellular carcinoma management in a liver transplant center from Romania Cerban R.1, Iacob S.1, Croitoru A.1, Popescu.
Presentation transcript:

Locally-Advanced HCC: Great Debates & Updates in GI Malignancies Debate: Locally-Advanced HCC: Surgery is Optimal Michael A. Choti, MD Department of Surgery UT Southwestern Medical Center Dallas, Texas

Disclosures Beyer Healthcare: research, consultant Bristol Mayer Squibb: research, consultant

Treatment Options for HCC CURATIVE THERAPIES: Liver Resection Liver Transplantation Tumor Ablation PALLIATIVE THERAPIES: Chemoembolization Chemotherapy Radiation Therapy

Management of HCC No cirrhosis Child A Extrahepatic Spread Locally Unresectable Resectable No cirrhosis Resectable Child A T1 or T2 (1/5 or 3/3 rule) with poor liver function (Child, B or C) Biopsy to confirm Small (<5cm) Large (>5cm) RFA PEI Palliative TACE or Systemic Chemotherapy Supportive Care TACE/Y90 Resection RFA Total Hepatectomy or Supportive Care

Operative Mortality for HCC: More Recent Series Author n % Cirr % Mort Torzilli (99) 107 60% 0% Midorikawa (99) 277 68% 0% Fong (99) 154 65% 4% Fan (99) 330 49% 6%

Results of Hepatectomy for HCC Author n 1-year surv (%) 5-year surv (%) Fong (1999) 100 83 42 Llovett (1999) 77 85 51 nl bili, no portal HT 35 91 74 Takayama (2000) 74 100 62 Arii (2000) Stage 1,<2cm 1318 96 72 Stage 1, 2-5cm 2722 95 58 Stage 2, <2cm 502 92 55 Stage 2, 2-5cm 1548 95 58 Grazi (2001) 264 86 40 Wayne (2002) 249 83 41

Milan/UNOS Criteria for Transplantation Single lesion of ≤ 5cm or 2 or 3 lesions, none > 3cm No gross vascular invasion No regional nodal or distant metastases

BCLC Staging System for HCC

BCLC Staging System for HCC A early single <5-cm or 3 nodules <3-cm each B intermediate Large, multi-nodular C advanced vascular invasion and/or extrahepatic disease

Liver Resection vs Intraarterial therapy? Framing the Debate Resectable Disease Child A Anatomically resectable Outside Milan criteria Locally Advanced Large size Multifocal disease Major vascular invasion Nodal involvement Liver Resection vs Intraarterial therapy?

Liver Resection for Multiple HCCs 367 TACE 404 BSC Retrospective cohort comparison National Taiwan University 1065 patients with multiple HCCs Ho et al. Ann Surg Onc (2009)

Resection vs TACE for Multiple HCCs: RCT 2 TUMORS >2 TUMORS

Multifocal HCC Prognosis and management can vary based on biology Satellitosis Multifocal (field defect) Intrahepatic metastases

Liver Resection for HCC Invading Major Portal and/or Hepatic Veins no portal vein involvement distal to second trunk within second trunk first branch main portal trunk

Liver Resection for HCC with Major Vein Involvement Large retrospective cohort study from Japan (94-11) Among 1523 HCC resections, major venous involvement: 153 portal vein 21 hepatic vein 13 IVC Mortality 2-5% Acceptable long-term outcome Worse survival with IVCTT Kokudo et al. J Hepatology (2014)

Liver Resection for Node Positive HCC positive hilar nodes

Potentially Resectable But Locally Advanced? Liver Resection TACE/Y-90/SRT or Liver Resection TACE/Y-90/SRT followed by Defines biology and improves patient selection Response can improve resectability

Thank You